1. Home
  2. LKQ vs SYRE Comparison

LKQ vs SYRE Comparison

Compare LKQ & SYRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo LKQ Corporation

LKQ

LKQ Corporation

HOLD

Current Price

$24.56

Market Cap

7.4B

ML Signal

HOLD

Logo Spyre Therapeutics Inc.

SYRE

Spyre Therapeutics Inc.

HOLD

Current Price

$71.20

Market Cap

6.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LKQ
SYRE
Founded
1998
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Motor Vehicles
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.4B
6.3B
IPO Year
2003
2015

Fundamental Metrics

Financial Performance
Metric
LKQ
SYRE
Price
$24.56
$71.20
Analyst Decision
Buy
Strong Buy
Analyst Count
6
12
Target Price
$42.33
$85.08
AVG Volume (30 Days)
3.1M
933.8K
Earning Date
04-30-2026
05-08-2026
Dividend Yield
3.91%
N/A
EPS Growth
N/A
N/A
EPS
2.35
N/A
Revenue
$13,651,000,000.00
N/A
Revenue This Year
$2.18
N/A
Revenue Next Year
$1.71
N/A
P/E Ratio
$10.52
N/A
Revenue Growth
N/A
N/A
52 Week Low
$24.57
$13.93
52 Week High
$40.94
$78.80

Technical Indicators

Market Signals
Indicator
LKQ
SYRE
Relative Strength Index (RSI) 24.05 54.33
Support Level N/A $67.18
Resistance Level $32.14 $76.16
Average True Range (ATR) 1.21 4.27
MACD -0.53 -0.94
Stochastic Oscillator 2.92 31.84

Price Performance

Historical Comparison
LKQ
SYRE

About LKQ LKQ Corporation

LKQ Corp is a world-wide distributor of vehicle products, including replacement parts, components and systems used in the repair and maintenance of vehicles, and specialty aftermarket products and accessories to improve the performance, functionality and appearance of vehicles. The company is organized into three operating segments: North America; Europe; and Specialty segment. It derives maximum revenue from Europe Segment. Europe segment is a provider of alternative vehicle replacement and maintenance products in Germany, the United Kingdom, the Benelux region (Belgium, Netherlands, and Luxembourg), Italy, Czech Republic, Austria, Slovakia, France and various other European countries.

About SYRE Spyre Therapeutics Inc.

Spyre Therapeutics Inc is a clinical-stage biotechnology company pioneering long-acting antibodies and antibody combinations to redefine the standard of care for inflammatory bowel disease (IBD) and rheumatic diseases. Spyre's pipeline includes extended half-life antibodies targeting α4β7, TL1A, and IL-23 in development as monotherapies and pair-wise combinations. It has a single reportable segment, which is the development of biopharmaceutical products for the treatment of patients with IBD and other immune-mediated disease.

Share on Social Networks: